Pages that link to "Q46668654"

The following pages link to Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007. (Q46668654):

Displaying 16 items.

• Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies (Q24632655) (← links)
• Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool (Q28551188) (← links)
• Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records (Q33683650) (← links)
• Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis (Q33880174) (← links)
• Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data (Q34099031) (← links)
• Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. (Q34514319) (← links)
• Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies (Q35894680) (← links)
• The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus (Q37306857) (← links)
• The safety of thiazolidinediones (Q37848841) (← links)
• Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis (Q38105641) (← links)
• Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort (Q38174445) (← links)
• Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations (Q38248399) (← links)
• Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future (Q38641190) (← links)
• Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons (Q39550978) (← links)
• Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study (Q39680117) (← links)
• Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial (Q88528326) (← links)